The significant reduction of CD133-positive cell after PEF-5 treatment (Figure 2), as a consequence of filopodia loss in D283 cells, suggests that it could alter tumor progression by making mitochondria more vulnerable to oxidative stress [53]. This evidence concerns the gene PROM1 and neoplasm.